Literature DB >> 23840013

Review: the utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23840013     DOI： 10.1002/art.38083

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  16 in total

1.  Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: what rheumatologists should know.

Authors:  Fabio Martino Doniselli; Domenico Albano; Vito Chianca; Marco Amedeo Cimmino; Luca Maria Sconfienza
Journal:  Clin Rheumatol       Date:  2017-03-20       Impact factor: 2.980

Review 2.  Imaging in rheumatoid arthritis: the role of magnetic resonance imaging and computed tomography.

Authors:  Mikkel Østergaard; Mikael Boesen
Journal:  Radiol Med       Date:  2019-03-18       Impact factor: 3.469

Review 3.  Progress in imaging in rheumatology.

Authors:  Emilio Filippucci; Luca Di Geso; Walter Grassi
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

4.  Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy.

Authors:  Veena K Ranganath; Kambiz Motamedi; Espen A Haavardsholm; Paul Maranian; David Elashoff; Fiona McQueen; Erin L Duffy; Joan M Bathon; Jeffrey R Curtis; Weiling Chen; Larry Moreland; James Louie; Sogol Amjadi; James O'Dell; Stacey S Cofield; E William St Clair; S Louis Bridges; Harold E Paulus
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

5.  MRI pattern of arthritis in systemic lupus erythematosus: a comparative study with rheumatoid arthritis and healthy subjects.

Authors:  Chiara Tani; Tani Chiara; Dario D'Aniello; D'aniello Dario; Niccolò Possemato; Possemato Niccolò; Andrea Delle Sedie; Delle Sedie Andrea; Davide Caramella; Caramella Davide; Stefano Bombardieri; Bombardieri Stefano; Marta Mosca; Mosca Marta
Journal:  Skeletal Radiol       Date:  2014-10-24       Impact factor: 2.199

Review 6.  Heading toward a modern imaging approach in juvenile idiopathic arthritis.

Authors:  Stefano Lanni; Alberto Martini; Clara Malattia
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

Review 7.  Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review.

Authors:  Thasia G Woodworth; Olga Morgacheva; Olga L Pimienta; Orrin M Troum; Veena K Ranganath; Daniel E Furst
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

8.  Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients.

Authors:  Kenzie D MacIsaac; Richard Baumgartner; Jia Kang; Andrey Loboda; Charles Peterfy; Julie DiCarlo; Jonathan Riek; Chan Beals
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

9.  The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy.

Authors:  Philip G Conaghan; Charles Peterfy; Ewa Olech; Jeffrey Kaine; David Ridley; Julie Dicarlo; Josh Friedman; Jenny Devenport; Orrin Troum
Journal:  Ann Rheum Dis       Date:  2014-02-13       Impact factor: 19.103

10.  Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques.

Authors:  Philip G Conaghan; Mikkel Østergaard; Michael A Bowes; Chunying Wu; Thomas Fuerst; Désirée van der Heijde; Fedra Irazoque-Palazuelos; Oscar Soto-Raices; Pawel Hrycaj; Zhiyong Xie; Richard Zhang; Bradley T Wyman; John D Bradley; Koshika Soma; Bethanie Wilkinson
Journal:  Ann Rheum Dis       Date:  2016-01-25       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.